Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
BMC Systems Biology|July 18, 2014
A diVIsive Shuffling Approach (VIStA) for gene expression analysis to identify subtypes in Chronic Obstructive Pulmonary DiseaseJörg Menche, Amitabh Sharma, Michael H Cho, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2020
Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal AnalysisZhang Wang, Nicholas Locantore, Koirobi Haldar, et al.
The European Respiratory Journal|December 11, 2020
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohortBartolome Celli, Nicholas Locantore, Julie C Yates, et al.
Respiratory Medicine|June 25, 2013
Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohortJoy Miller, Lisa D Edwards, Alvar Agustí, et al.
American Journal of Respiratory and Critical Care Medicine|January 11, 2011
Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary diseaseDon D Sin, Bruce E Miller, Annelyse Duvoix, et al.
Plos One|May 25, 2012
Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypeAlvar Agustí, Lisa D Edwards, Stephen I Rennard, et al.
The New England Journal of Medicine|October 14, 2011
Changes in forced expiratory volume in 1 second over time in COPDJørgen Vestbo, Lisa D Edwards, Paul D Scanlon, et al.
Annals of the American Thoracic Society|February 3, 2015
Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysisStephen I Rennard, Nicholas Locantore, Bruno Delafont, et al.
American Journal of Respiratory and Critical Care Medicine|April 5, 2022
Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease StudyJean Bourbeau, Dany Doiron, Sharmistha Biswas, et al.
The European Respiratory Journal|September 25, 2020
A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPDPei Yee Tiew, Alison J Dicker, Holly R Keir, et al.
Pageof 11